BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
The Company held its 2018 annual stockholder meeting on May 23, 2018. The following matters were each submitted to a vote of stockholders through the solicitation of proxies or otherwise:
|
1. |
A proposal to elect the following seven individuals to our Board of Directors: Dennis P. Calvert, Kenneth R. Code, Dennis E. Marshall, Joseph L. Provenzano, Kent C. Roberts II, John S. Runyan and Jack B. Strommen. |
|
2. |
Advisory approval of the Company’s executive compensation. |
|
3. |
A proposal to ratify the appointment of Haskell & White LLP as our independent public accounting firm for the 2018 fiscal year. |
|
4. |
A proposal to increase the authorized capital stock of the Company from 200,000,000 shares of common stock to 400,000,000 shares of common stock. |
|
5. |
A proposal to adopt the 2018 Equity Incentive Plan. |
A quorum was present in person or by proxy. Each matter was approved. The voting results are as follows:
|
Proposal One |
Votes For |
Votes Withheld |
Broker Non-Vote |
Total Votes (For + Withheld) |
|
|
Dennis P. Calvert |
34,827,821 |
640,290 |
35,954,467 |
35,468,111 |
|
|
Kenneth R. Code |
34,848,821 |
619,290 |
35,954,467 |
35,468,111 |
|
|
Dennis E. Marshall |
35,086,896 |
381,215 |
35,954,467 |
35,468,111 |
|
|
Joseph L. Provenzano |
34,737,572 |
730,539 |
35,954,467 |
35,468,111 |
|
|
Kent C. Roberts II |
35,234,614 |
233,497 |
35,954,467 |
35,468,111 |
|
|
John S. Runyan |
35,204,734 |
263,377 |
35,954,467 |
35,468,111 |
|
|
Jack B. Strommen |
35,113,776 |
354,335 |
35,954,467 |
35,468,111 |
|
|
Proposals 2 – 5 |
Votes For |
Votes Against |
Votes Abstain |
Broker Non- Vote |
Total votes |
|
|
34,117,919 |
1,102,804 |
247,388 |
35,954,467 |
35,468,111 |
|
|
69,640,818 |
357,915 |
1,423,844 |
– |
71,422,577 |
|
|
60,800,613 |
7,946,285 |
2,596,033 |
79,647 |
71,342,931 |
|
|
33,976,146 |
1,201,591 |
290,374 |
35,954,467 |
35,468,111 |
For the Advisory Approval of Executive Compensation, prior year votes are as follows:
|
Year |
Votes For |
Votes Against |
Votes Abstain |
Broker Non-Vote |
|
|
27,248,643 |
343,971 |
242,499 |
28,177,525 |
|
|
31,052,733 |
342,142 |
240,267 |
21,119,013 |
There were no director nominees other than as set forth above.
About BioLargo, Inc. (OTCMKTS:BLGO)
BioLargo, Inc. is a provider of platform technologies. The Company’s products are used to eliminate contaminants that threaten the water, health and quality of life. Its technology has commercial applications within several industries. The Company focuses on four areas: water treatment; industrial odor control applications; commercial, household and personal care products (CHAPP), and advanced wound care. Its AOS Filter combines iodine, water filter materials and electrolysis within a water filter device. It generates oxidation potential in order to oxidize and breakdown or otherwise eliminate, soluble organic contaminant, which are found in contaminated water. Its CupriDyne formula is used to deliver iodine within products. The Isan System is an automated iodine dosing system, which features controlled measuring, flow control, dosing and iodine extraction and removal technology, as well as an automatic tracking system that delivers iodine in calibrated doses.